Design of the quasi-experimental study.

<p>Design of the quasi-experimental study.</p

Is systematic training in opioid overdose prevention effective? - Fig 2

<p>Distribution of people who injected opioids recruited through harm reduction centers in Catalonia according to the number of a) correct and b) incorrect answers about overdose risk factors, and adequate/inadequate actions for reversing or minimizing the effects of an overdose.</p

Knowledge about overdose prevention: cited causes of overdose, and actions to take when this happens, according to the pre-implementation, comparison, and intervention groups.

<p>Knowledge about overdose prevention: cited causes of overdose, and actions to take when this happens, according to the pre-implementation, comparison, and intervention groups.</p

Use of naloxone when witnessing an overdose in the intervention group.

<p>Use of naloxone when witnessing an overdose in the intervention group.</p

Correct or incorrect answers about causes or actions in overdose prevention among people who injected opioids recruited at harm reduction centers in Catalonia before and after the implementation of Systematic Training in Opioid Overdose Prevention in Catalonia.

<p>Correct or incorrect answers about causes or actions in overdose prevention among people who injected opioids recruited at harm reduction centers in Catalonia before and after the implementation of Systematic Training in Opioid Overdose Prevention in Catalonia.</p

Additional file 1 of A clinical utility evaluation of dual HIV/Syphilis point-of-care tests in non-clinical settings for screening for HIV and syphilis in men who have sex with men

Additional file 1. Syphilis and HIV dual POCTS and routine test results. Table describing syphilis and HIV dual POCTs and routine test results

Prevalence curve of HR-HPV infection by age group.

<p>Prevalence curve of HR-HPV infection by age group.</p

Multivariate analysis^† of the characteristics associated with high-risk HPV infection.

†<p>The model included those variables that were statistically significant in the univariate analysis (p-value<0.05), those with a p-value lower than 0.10, and those that were considered clinicoepidemiologically important.</p>*<p>Adjustment variables introduced in the final model.</p

Main differential characteristics of the study population according to the results of HC2 and Pap smear.

*<p>X² test for linear trend.</p>**<p>(low-grade squamous intraepithelial lesion and high grade squamous intraepithelial lesion).</p>§<p>during the last 6 months.</p

Main sociodemographic, behavioral, and clinical characteristics of the study population (n = 479).

†<p>Present the valid percent, the total sample was n = 479 but there were some missings data.</p>*<p>Performed at the first visit to the study gynecologist.</p>§<p><i>medical records</i>.</p>a<p>HAART was defined as the combination of at least 3 antiretroviral drugs.</p><p>Abbreviations: IVDU, intravenous drug user; STI, sexually transmitted infection; HAART, highly active antiretroviral infection; ASC-US, atypical squamous cells of undetermined significance; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion.</p